In this free webinar, learn how to design more effective central nervous system (CNS) drug delivery studies and avoid common pitfalls in the field. Attendees will gain insights into techniques for direct injection into specific brain regions and intrathecal spaces. The featured speakers will discuss novel techniques in visualizing gene transport using fluorescent tagging and tomography imaging. Attendees will also learn about the measurement of biodistribution and biological endpoints in CNS studies. Additionally, the speakers will discuss the role of MRI guidance in ensuring accurate drug delivery and minimizing off-target effects.
TORONTO, March 31, 2025 /PRNewswire-PRWeb/ -- In this webinar, the attendees will gain insights into the latest research methodologies used to optimize central nervous system (CNS)-targeted drug delivery.
A key highlight of the webinar will be the presentation of novel data from a pilot study. This study utilized adeno-associated virus (AAV)-based gene therapy with fluorescent tagging, allowing for advanced visualization of biodistribution through histological and tomography-based imaging techniques.
During the webinar, the speakers will discuss a groundbreaking approach where a fluorescent-tagged transgene was delivered via AAV to the brain, enabling visualization using histological techniques and tomography imaging. This innovative approach allowed researchers to generate highly detailed 3D reconstructions of biodistribution patterns, layered with magnetic resonance imaging (MRI) anatomical data to create a comprehensive visualization of gene transport. This type of data is invaluable for researchers designing CNS-targeted drug delivery programs as it provides both qualitative and quantitative insights into treatment efficacy and precision.
The webinar will also address translational considerations for CNS drug delivery. The speakers' insights will be particularly valuable for professionals looking to bridge the gap between preclinical research and clinical implementation.
Register for this webinar to gain a clear understanding of how to design more effective CNS drug delivery studies and avoid common pitfalls in the field.
Join Jake McDonald, PhD, ATS, CEO, ; Dr. Reinier Espinosa, Lead Surgeon and Study Director, Envol Biomedical; and Dr. Ernesto Salegio, PhD, Vice President, Segment Leader Translational & Pre-Clinical Research, ClearPoint Neuro, for the on Wednesday, April 16, 2025, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit
For information about hosting a webinar visit
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected],
SOURCE Xtalks
Share this article